Cassava Patient Family Testimonial, Manny's Story, goes live at 2pm Today youtu.be/TEl6SbXR5hc Cure Guardian has finished a video highlighting the experiences of one patient that has been on simufilam for 4 years. The drug is the only thing that changed in his life and it reversed his symptoms of #Alzheimers Simufilam is a drug that is in phase 3 trials from Cassava Sciences, $sava, and results will be out before the end of 2024. The video we are playing at 2pm EST on November 15th is one of MANY stories that we are hearing from patients and their families. We believe the data release before the end of the year will show simufilam is the biggest breakthrough in the Unfortunately, this drug has been attacked by short sellers and competitors. It is very important that the @US_FDA do not give into the pressure from short sellers and big pharma and they approve the drug as soon as possible. @RobertKennedyJr we need your support of researchers and biotechs innovating and finding cures to disease! These attacks successfully got the attention of the @DOJCrimDiv and they raided the researchers home at 9pm on a Monday days after the shorts released their reports. Dr. Wang has been a victim of massive government overreach and, I believe, the world will soon see that his drug is the biggest breakthrough in Alzheimer's research. He is was indicted earlier this year and has a motion to dismiss hearing on December 13th. I have been an advocate for the families that are in the clinical trials for 3 years now. I even formed a non-profit so others can join the fight against shaming researchers and biotechs pursuing cures to disease. We help researchers fend off the public attacks. 96.5% of accusations to the NIH and ORI result in finding of no research misconduct. cureguardian.org youtu.be/TEl6SbXR5hc